Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents
BackgroundPercutaneous coronary intervention (PCI) in patients with previous coronary artery bypass grafting (CABG) is associated with adverse clinical events. Although newer generation drug‐eluting stents showed favorable short‐term safety profiles, there is a lack of long‐term outcome data. We eva...
Main Authors: | Liefke C. van der Heijden, Marlies M. Kok, Paolo Zocca, Hanim Sen, Marije M. Löwik, Silvia Mariani, Frits H. A. F. de Man, Marc Hartmann, Martin G. Stoel, K. Gert van Houwelingen, J. (Hans) W. Louwerenburg, Gerard C. M. Linssen, Carine J. M. Doggen, Jan G. Grandjean, Clemens von Birgelen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-02-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.117.007212 |
Similar Items
-
Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers
by: Eline H. Ploumen, et al.
Published: (2022-11-01) -
Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
by: Raghav Sharma, et al.
Published: (2022-02-01) -
Primary percutaneous coronary intervention in CAD patients: A comparison of major adverse cardiovascular events of second- and third-generation drug-eluting stents
by: Salma Bibi, et al.
Published: (2022-11-01) -
Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials
by: Eline H. Ploumen, et al.
Published: (2021-10-01) -
Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
by: Iraj Jafaripour, et al.
Published: (2023-05-01)